Literature DB >> 30110051

How to Evaluate Cardiac Autonomic Modulation.

Esteban W Rivarola1, Mauricio I Scanavacca1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30110051      PMCID: PMC6078378          DOI: 10.5935/abc.20180127

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
Cardiac autonomic nervous system dysfunction has been implicated in several different pathological scenarios with a wide range of clinical relevance and risk. Early detection of autonomic changes, either provoked for therapeutic purposes[1] or as a complication of a primary disorder, such as diabetes mellitus (DM) is of essence for the best management of patients. Classic (linear) analysis of heart rate variability (HRV) has been routinely used to assess autonomic behavior in diabetic patients in order to promptly detect neuropathy,[2] one of the most common and overlooked complications and a significant cardiovascular risk factor. As the linear analysis provides important data, non-linear indexes of HRV have been proposed as well, emerging as potential ancillary tools to investigate dysautonomia in type 1 and 2 DM. In the paper “Nonlinear Dynamics in young people with diabetes”,[3] the authors compared linear and nonlinear indexes and studied their correlation. While symbolic analysis presented partial correlation with linear methods, Shannon entropy index was similar in DM individuals and controls, and these findings raise two important issues: What could be the clinical value of determining the complexity and randomness of HRV by nonlinear methods? Are they sensitive and efficient? Several authors agreed that linear indexes (time and frequency domains) are simple and reproducible methods to evaluate the cardiac autonomic system and are consistently reduced in diabetic patients.[2-7] The observed lack of correlation of nonlinear methods with standard measures may imply low sensitivity, and it stands in disagreement with Javorka et al.,[4] which claim that “The complexity of HRV appears to be even more affected (in DM patients) than the magnitude of HRV that is commonly assessed by cardiac autonomic tests.” On the other hand, a perfect correlation between nonlinear techniques and standard HRV measures would provide only limited additional diagnostic information. In fact, previous authors verified that linear HRV indexes performed even better than most complexity measures in discriminating DM patients from controls.[4] So, where do we stand on the noninvasive diagnosis of dysautonomia? To the best of our knowledge, time and frequency domain indexes remain the most accepted and used methods to assess HRV. Nonlinear measures are potential tools, but to reach optimal HRV assessment, the methods must be standardized: it is possible to find studies with 24-hour,[8] medium-term (~1h),[4,7] ultra short-term (<5 min)[9] and short-term (from 5-10 min)[2,5,6,10] data recording indexes, all of them dealing with noninterchangeable information. Nonlinear methods’ contribution to evaluate diabetic autonomic system dysfunction is yet to be demonstrated by large-scale comparison studies. Once complexity evaluation proves its value, however, one last question will remain: to what extent would it help patients prevent diabetic neuropathy progression?
  9 in total

1.  Nonlinear PD2i heart rate complexity algorithm detects autonomic neuropathy in patients with type 1 diabetes mellitus.

Authors:  James E Skinner; Daniel N Weiss; Jerry M Anchin; Zuzana Turianikova; Ingrid Tonhajzerova; Jana Javorkova; Kamil Javorka; Mathias Baumert; Michal Javorka
Journal:  Clin Neurophysiol       Date:  2011-01-21       Impact factor: 3.708

2.  Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation.

Authors:  Stefano Guzzetti; Ester Borroni; Pietro E Garbelli; Elisa Ceriani; Paolo Della Bella; Nicola Montano; Chiara Cogliati; Virend K Somers; Alberto Malliani; Alberto Mallani; Alberto Porta
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

3.  Targets and End Points in Cardiac Autonomic Denervation Procedures.

Authors:  Esteban W Rivarola; Denise Hachul; Tan Wu; Cristiano Pisani; Carina Hardy; Fabrizio Raimundi; Sissy Melo; Francisco Darrieux; Mauricio Scanavacca
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-02

4.  Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes.

Authors:  Nedim Soydan; Reinhard G Bretzel; Britta Fischer; Florian Wagenlehner; Adrian Pilatz; Thomas Linn
Journal:  Metabolism       Date:  2013-01-12       Impact factor: 8.694

5.  Short-term heart rate complexity is reduced in patients with type 1 diabetes mellitus.

Authors:  Michal Javorka; Zuzana Trunkvalterova; Ingrid Tonhajzerova; Jana Javorkova; Kamil Javorka; Mathias Baumert
Journal:  Clin Neurophysiol       Date:  2008-03-04       Impact factor: 3.708

6.  Dynamics of heart rate variability analysed through nonlinear and linear dynamics is already impaired in young type 1 diabetic subjects.

Authors:  Naiara M Souza; Thais R Giacon; Francis L Pacagnelli; Marianne P C R Barbosa; Vitor E Valenti; Luiz C M Vanderlei
Journal:  Cardiol Young       Date:  2016-02-03       Impact factor: 1.093

7.  Influence of type 2 diabetes on symbolic analysis and complexity of heart rate variability in men.

Authors:  Sílvia Cg Moura-Tonello; Anielle Cm Takahashi; Cristina O Francisco; Sérgio Lb Lopes; Adriano M Del Vale; Audrey Borghi-Silva; Angela Mo Leal; Nicola Montano; Alberto Porta; Aparecida M Catai
Journal:  Diabetol Metab Syndr       Date:  2014-02-01       Impact factor: 3.320

8.  Nonlinear methods to assess changes in heart rate variability in type 2 diabetic patients.

Authors:  Bhaskar Roy; Sobhendu Ghatak
Journal:  Arq Bras Cardiol       Date:  2013-09-06       Impact factor: 2.000

9.  Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Mamta Jaiswal; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Tasha E Fingerlin; Stephen Daniels; Santica M Marcovina; Lawrence M Dolan; Dana Dabelea
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.